Default: JACC: Heart Failure

ISSN: 2213-1779

Journal Home

Journal Guideline

JACC: Heart Failure Q1 Unclaimed

Elsevier BV Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

JACC: Heart Failure is a journal indexed in SJR in Cardiology and Cardiovascular Medicine with an H index of 67. It has an SJR impact factor of 6,123 and it has a best quartile of Q1. It has an SJR impact factor of 6,123.

JACC: Heart Failure focuses its scope in these topics and keywords: heart, failure, prognosis, program, preserved, pediatric, patients, nonobstructive, myocardial, reduced, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

JACC: Heart Failure

6,123

SJR Impact factor

67

H Index

184

Total Docs (Last Year)

596

Total Docs (3 years)

2888

Total Refs

2708

Total Cites (3 years)

262

Citable Docs (3 years)

4,38

Cites/Doc (2 years)

15,70

Ref/Doc

Aims and Scope


heart, failure, prognosis, program, preserved, pediatric, patients, nonobstructive, myocardial, reduced, targets, therapy, training, added, artery, chronic, dilated, disease, limited, inflammatory, incompetentlyimportance, biomarkers, cardiomyopathy, chronotropy, circulating, coronary, diabetes, ejection, failuredistinct, failureobesity, fellows, fractionjacc, generationare,



Best articles by citations

The Globalization of Heart Failure Research

View more

A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation

View more

Impaired Alveolar Capillary Membrane Diffusion

View more

Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial

View more

Cerebral Hypoperfusion Is Exaggerated With an Upright Posture in Heart Failure

View more

Incidence, Temporal Trends, and Prognostic Impact of Heart Failure Complicating Acute Myocardial Infarction

View more

Measurement to Predict Survival: The Case of Diastolic Pulmonary Gradient

View more

Time for Recognition

View more

G-Protein Beta-3 Subunit Genotype Predicts Enhanced Benefit of Fixed-Dose Isosorbide Dinitrate and Hydralazine

View more

Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population

View more

Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction

View more

Perhexiline, Cardiac Energetics, and Heart Failure

View more
SHOW MORE ARTICLES

Perhexiline: Lessons for Heart Failure Therapeutics *

View more

Light Chains and the Failing Heart

View more

Influenza Vaccination in Patients With Chronic Heart Failure

View more

Is Pump the Answer to Heart Failure With Preserved Ejection Fraction?

View more

The Ongoing Evolution of Optimal Clinical Endpoints for Heart Failure Trials *

View more

Beta-Blockers in Acute Heart Failure

View more

Clinical Outcomes With Use of Erythropoiesis Stimulating Agents in Patients With the HeartMate II Left Ventricular Assist Device

View more

Low-Dose Aspirin in Heart Failure Not Complicated by Atrial Fibrillation

View more

Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure

View more

Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival

View more

Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP

View more

The Association Between Atrial Fibrillation and Sudden Cardiac Death

View more

Comments

No comments ... Be the first to comment!

FAQS